Personalised Medicine in Cervical Cancer: Evaluating Therapy Resistance Through Multi‐Model Approaches.
- Published in:
- Cancer Medicine, 2025, v. 14, n. 13, p. 1, doi. 10.1002/cam4.70995
- By:
- Publication type:
- Article
Works by van der Merwe, Frederick H.
Results: 5
1
2
Validation of ASCL1 and LHX8 Methylation Analysis as Primary Cervical Cancer Screening Strategy in South African Women with Human Immunodeficiency Virus.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 3, p. 416, doi. 10.1093/cid/ciac801
- By:
- Publication type:
- Article
3
Exploring the feasibility of using mobile phones to improve the management of clients with cervical cancer precursor lesions.
- Published in:
- 2019
- By:
- Publication type:
- journal article
4
The performance of single and combination test strategies using visual inspection, cytology, high-risk HPV DNA and HPV16/18 to screen South African women with and without HIV-infection.
- Published in:
- Infectious Agents & Cancer, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s13027-024-00586-3
- By:
- Publication type:
- Article
5
A Review: Genetic Mutations as a Key to Unlocking Drug Resistance in Cervical Cancer.
- Published in:
- Cancer Control: Journal of the Moffitt Cancer Center, 2024, v. 31, p. 1, doi. 10.1177/10732748241261539
- By:
- Publication type:
- Article